Reading time: 5 minutes Colette Bilynsky The American Cancer Society has found colorectal cancer to be the 3rd highest cause of cancer deaths and 3rd highest estimated new cases in both men and women in 2022 [1]. The risk of colorectal cancer is significantly higher in people with inflammatory bowel disease (IBD): ulcerative colitis (UC),... Continue Reading →
CAR-Macrophages: A New Take on an Immunotherapy Classic
Colette Bilynsky CAR-T cell therapy is widely available in the United States, with 6 FDA-approved formulations, and has been previously discussed on Oncobites. However, a new clinical trial using the CAR (chimeric antigen receptor) technology is underway, but using macrophages instead of T-Cells in the hope of treating more types of cancer. But let’s take... Continue Reading →